Across TCGA pan-cancer cohorts, RNU6-1172P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-1172P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1172P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1172P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

OV, KIRC, and ESCA are the cancer types where RNU6-1172P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.059	0.844	<.001	144	view →
KIRC	DFS	Tertile	All	0.123	0.627	.003	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-1172P tumor-vs-normal RNA expression · all RNU6-1172P data types